JUST IN: Nasdaq-listed healthcare firm Prenetics holds 228 Bitcoin and is buying 1 Bitcoin per day for its treasury.This will become more and more common ✅ https://t.co/N0WREuP0Qa ...

🚨JUST IN: NASDAQ-listed Prenetics now holds 228 $BTC and is buying 1 $BTC per day. https://t.co/AvSmGVfw3L ...

1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics provides update on Bitcoin Treasury, adding a total of 228 Bitcoin, and accumulating 1 BTC daily Prenetics to achieve break-even in Q1 2026, and EBITDA positive moving forward CHARLOTTE, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Compan ...

1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics provides update on Bitcoin Treasury, adding a total of 228 Bitcoin, and accumulating 1 BTC daily Prenetics to achieve break-even in Q1 2026, and EBITDA positive moving forward CHARLOTTE, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Compan ...

Aryna Sabalenka becomes first woman to defend US Open title in more than a decadeAI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US OpenIM8 achieves 300,000+ customer purchases and 6 million servings in just 9 months since launch CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, and its premium supplement brand IM8, co-founded by David Beckham, today extends heartfelt congratulat ...

Core Viewpoint - Honeywell announced a $600 million equity capital raise for Quantinuum, valuing the company at $10 billion pre-money, aimed at advancing quantum computing technology [1][3]. Company Overview - Quantinuum is recognized as the world's highest-performing quantum computer developer, focusing on commercially useful quantum computing solutions [4][11]. - The company employs over 630 staff, including more than 370 scientists and engineers, across multiple countries [11]. Investment and Partnerships - Existing shareholders, including JPMorganChase, Mitsui, and Amgen, along with new investors like MESH and Korea Investment Partners, participated in the funding round [2]. - The capital raise will support the launch of Helios, Quantinuum's next-generation quantum computing system, expected this year [3]. Technological Advancements - Quantinuum aims to achieve universal fault-tolerant computing, enhancing its leadership in the quantum computing sector [3]. - The company is collaborating with NVIDIA on breakthroughs at the NVIDIA Accelerated Quantum Research Center [5]. Strategic Collaborations - Quantinuum has formed partnerships with organizations such as RIKEN, SoftBank Corp., and Infineon to expand its quantum computing capabilities [5]. - A joint venture in Qatar will deliver advanced quantum computing infrastructure as part of a $1 billion investment over the next decade [6]. Market Impact - The company's solutions are driving scientific discoveries, economic growth, and sustainable development, positioning it as a leader in the quantum technologies industry [4][6]. - Quantinuum's advancements are expected to enhance classical artificial intelligence capabilities and contribute to next-generation technologies [5].

Core Insights - Prenetics Global Limited announced a partnership between its premium supplements brand IM8 and world No. 1 tennis player Aryna Sabalenka, who becomes the brand's global ambassador and shareholder [1][6][12] - This partnership is significant as it marks the first endorsement of a supplement brand by Sabalenka, who has reported substantial benefits from using IM8's Daily Ultimate Essentials [3][4][5] Company Overview - Prenetics is a leading consumer health sciences company listed on NASDAQ under the ticker PRE, focusing on advancing consumer health through various initiatives, including IM8 [10] - IM8, co-founded by David Beckham, has rapidly grown to generate over US$50 million in Annual Recurring Revenue within just six months of its launch [6][8] - IM8 has built a loyal customer base of over 60,000 users, delivering more than 5 million servings of its products [6][8] Product Details - IM8's flagship product, Daily Ultimate Essentials, is designed to replace 16 different supplements with a single, NSF Certified for Sport® powder supplement [11] - The product is non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners [11] Market Context - The partnership comes at a time when supplement safety and quality are critical issues in professional sports, with IM8's NSF Certified for Sport® designation ensuring rigorous testing for prohibited substances [7] - IM8's revenue growth trajectory exceeds typical benchmarks for successful supplement launches by 500%, indicating strong market demand and acceptance [8]

Core Insights - Prenetics Global Limited announced a partnership between its premium supplements brand IM8 and world No. 1 tennis player Aryna Sabalenka, who becomes the brand's global ambassador and shareholder [1][6][12] - This partnership is significant as it marks the first endorsement of a supplement brand by Sabalenka, who has reported substantial benefits from using IM8's Daily Ultimate Essentials [3][4][6] Company Overview - Prenetics is a leading consumer health sciences company listed on NASDAQ under the ticker PRE, focusing on advancing consumer health through innovative products [10] - IM8, co-founded by David Beckham, is a rapidly growing health and wellness brand that has achieved over US$50 million in Annual Recurring Revenue within six months of its launch [6][8][11] Product Details - IM8's flagship product, Daily Ultimate Essentials, is designed to replace 16 different supplements with a single, NSF Certified for Sport® powder supplement, ensuring safety and efficacy for athletes [11][12] - The product has gained a loyal customer base of over 60,000 users, who have consumed more than 5 million servings [6][8] Market Position - IM8 is recognized as one of the fastest-growing supplement brands globally, with its revenue velocity exceeding typical benchmarks for successful launches by 500% [8] - The partnership with Sabalenka comes at a time when supplement safety and quality are critical issues in professional sports, highlighting the importance of IM8's NSF certification [7][8] Athlete Endorsement - Aryna Sabalenka's personal experience with IM8 has led her to not only endorse the brand but also invest in it, reflecting her confidence in the product's quality and effectiveness [5][7] - The collaboration emphasizes the alignment of Sabalenka's values of athletic excellence and professionalism with IM8's commitment to quality and innovation [7][9]

Core Insights - Prenetics Global Limited has become the first healthcare company to establish a Bitcoin treasury, completing a $20 million purchase of 187.42 BTC at an average price of $106,712 per Bitcoin [2][17] - The company aims to significantly increase its Bitcoin holdings and become one of the largest corporate Bitcoin holders in the healthcare sector, inspired by strategies from MicroStrategy and Metaplanet [1][3][8] - Prenetics has appointed Andy Cheung, former COO of OKEx, to its Board of Directors to provide strategic oversight for its Bitcoin treasury initiative [3][5] Financial Strategy - Prenetics has a strengthened balance sheet with over $117 million in total liquidity, including approximately $66 million in cash reserves and a debt-free balance sheet [15] - The Board has approved a majority allocation of its balance sheet to Bitcoin, demonstrating a strong commitment to digital asset adoption [9] - The company is actively discussing partnerships with leading financial institutions to develop a long-term Bitcoin acquisition plan [10] Operational Integration - Prenetics plans to accept cryptocurrency payments across its direct-to-consumer platforms, creating a seamless Bitcoin ecosystem from treasury to operations [11] - The company is implementing sophisticated alpha-generating strategies to maximize returns on its Bitcoin holdings, including yield generation and strategic lending [10] Business Growth - Prenetics has increased its full-year 2025 revenue guidance to $80-100 million, indicating confidence in its core business trajectory [12] - The company has achieved significant growth with over 55,000 customers and a 91% subscription rate across its health brands [14] Leadership and Expertise - The strategic appointment of industry leaders like Andy Cheung and Tracy Hoyos Lopez enhances Prenetics' credibility and operational guidance in the crypto space [5][13] - The company is leveraging the expertise of its advisory team to navigate the complexities of corporate Bitcoin adoption and to architect the future intersection of healthcare and digital assets [7][8]

Core Viewpoint - Prenetics Global Limited has announced the divestment of its majority stake in ACT Genomics to Delta Electronics for up to US$71.78 million, enhancing its financial position and focusing on high-growth consumer health brands [1][3][5] Financial Position - The divestment will provide Prenetics with approximately US$46 million in cash, increasing its pro-forma cash reserves to about US$86 million and pro-forma short-term assets to US$117 million, while maintaining a debt-free balance sheet [1][8][17] - Prenetics raised its FY2025 revenue outlook to US$80 – US$100 million from the previous US$73 – US$85 million, driven by the growth of its IM8 brand [5][6] Strategic Transformation - The divestment is part of Prenetics' strategic transformation to simplify its business model and enhance financial flexibility, allowing for accelerated growth in the consumer health market [3][11] - Prenetics now focuses on three consumer health brands: IM8, CircleDNA, and Europa, which are expected to synergistically enhance its market position [4][7][11] Market Performance - Prenetics' consumer health business has shown significant momentum, with Q1 2025 revenue of US$14.4 million, representing a 336.5% year-over-year increase, and a projected Q2 revenue of US$8.5 million [6][8] - The company has acquired over 55,000 customers and achieved a 91% subscription rate, indicating strong market demand [6][8] Innovation and Future Outlook - With a robust cash position, Prenetics is positioned to explore innovative treasury management strategies, including digital asset adoption and Bitcoin treasury strategies [10][11] - The company maintains a 35% stake in Insighta, valued at US$70 million, which adds significant value for shareholders [9]